Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Polymorphic Light Eruption (PLE) Mitigation: MT-I has been reported to minimize the severity of rashes in PLE patients when administered as 16mg implants over a 4-month duration, per a 2010 phase-3 trial [19]
Only the frequency and individual injection volume change
The CNS immune landscape from the viewpoint of a T cell
pharmacies, including FDA-registered compounding pharmacies when clinically appropriate
An earlier double-blind RCT by Arjinpathana and Asawanonda published in the Journal of Dermatological Treatment in 2012 (n=60, oral GSH 500 mg/day for 4 weeks) found that oral glutathione produced a modest skin-lightening effect in sun-exposed areas versus placebo, establishing the foundational clinical signal for the oral route
Therefore, they opted to look for a more stable and potent alternative that would be more practical
